These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 30259601)
1. Safety and efficacy of a 52-mg levonorgestrel-releasing intrauterine system in women with cardiovascular disease. Ueda Y; Kamiya CA; Horiuchi C; Miyoshi T; Hazama R; Tsuritani M; Iwanaga N; Neki R; Ikeda T; Yoshimatsu J J Obstet Gynaecol Res; 2019 Feb; 45(2):382-388. PubMed ID: 30259601 [TBL] [Abstract][Full Text] [Related]
2. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Critchley HO; Wang H; Kelly RW; Gebbie AE; Glasier AF Hum Reprod; 1998 May; 13(5):1210-7. PubMed ID: 9647549 [TBL] [Abstract][Full Text] [Related]
3. The influence of the levonorgestrel-releasing intrauterine system position on bleeding patterns in reproductive age women. Alves RDMS; Rabelo MM; Andrade VR; Cabral RCS; Merriman JW; Brito MB Int J Gynaecol Obstet; 2019 Dec; 147(3):326-331. PubMed ID: 31489621 [TBL] [Abstract][Full Text] [Related]
4. Endothelial function in women using levonorgestrel-releasing intrauterine system (LNG-IUS). Selim MF; Hussein AF Contraception; 2013 Apr; 87(4):396-403. PubMed ID: 23332246 [TBL] [Abstract][Full Text] [Related]
5. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial. Papaikonomou K; Kopp Kallner H; Söderdahl F; Gemzell-Danielsson K Hum Reprod; 2018 Nov; 33(11):2002-2009. PubMed ID: 30295731 [TBL] [Abstract][Full Text] [Related]
6. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System. Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999 [TBL] [Abstract][Full Text] [Related]
7. The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial. Gemzell-Danielsson K; Apter D; Hauck B; Schmelter T; Rybowski S; Rosen K; Nelson A PLoS One; 2015; 10(9):e0135309. PubMed ID: 26378938 [TBL] [Abstract][Full Text] [Related]
8. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception. Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577 [TBL] [Abstract][Full Text] [Related]
9. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems. Wildemeersch D; Janssens D; Vrijens M; Weyers S Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138 [TBL] [Abstract][Full Text] [Related]
10. The Femilis LNG-IUS: contraceptive performance-an interim analysis. Wildemeersch D; Janssens D; Andrade A Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705 [TBL] [Abstract][Full Text] [Related]
11. Levonorgestrel-Releasing Intrauterine System for Women With Polycystic Ovary Syndrome: Metabolic and Clinical Effects. da Silva AV; de Melo AS; Barboza RP; de Paula Martins W; Ferriani RA; Vieira CS Reprod Sci; 2016 Jul; 23(7):877-84. PubMed ID: 26733500 [TBL] [Abstract][Full Text] [Related]
12. Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years. Nelson AL Expert Rev Clin Pharmacol; 2017 Aug; 10(8):833-842. PubMed ID: 28617060 [TBL] [Abstract][Full Text] [Related]
13. Differences in continuation rates and early removal between contraceptive and therapeutic use of the levonorgestrel-releasing intrauterine system 52 mg. Teunissen AM; Merry AHH; Devies IEC; Roumen FJME Eur J Contracept Reprod Health Care; 2019 Dec; 24(6):449-456. PubMed ID: 31696740 [No Abstract] [Full Text] [Related]
14. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system. Sturridge F; Guillebaud J Drug Saf; 1996 Dec; 15(6):430-40. PubMed ID: 8968696 [TBL] [Abstract][Full Text] [Related]
15. Ease of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidas. Bahamondes MV; Hidalgo MM; Bahamondes L; Monteiro I Contraception; 2011 Nov; 84(5):e11-6. PubMed ID: 22018132 [TBL] [Abstract][Full Text] [Related]
16. Morphological and functional features of endometrial decidualization following long-term intrauterine levonorgestrel delivery. Critchley HO; Wang H; Jones RL; Kelly RW; Drudy TA; Gebbie AE; Buckley CH; McNeilly AS; Glasier AF Hum Reprod; 1998 May; 13(5):1218-24. PubMed ID: 9647550 [TBL] [Abstract][Full Text] [Related]
17. Why perimenopausal women should consider to use a levonorgestrel intrauterine system. Wildemeersch D Gynecol Endocrinol; 2016 Aug; 32(8):659-661. PubMed ID: 26930021 [TBL] [Abstract][Full Text] [Related]
18. LNG-IUS 12: a 19.5 levonorgestrel-releasing intrauterine system for prevention of pregnancy for up to five years. Nelson AL Expert Opin Drug Deliv; 2017 Sep; 14(9):1131-1140. PubMed ID: 28696796 [TBL] [Abstract][Full Text] [Related]
19. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women. Lehtovirta P; Paavonen J; Heikinheimo O Contraception; 2007 Jan; 75(1):37-9. PubMed ID: 17161122 [TBL] [Abstract][Full Text] [Related]
20. Bleeding pattern difference between levonorgestrel intrauterine system and copper intrauterine devices inserted immediately post-abortion: a multicenter, prospective, observational cohort study in Chinese women. Chen X; Li Q; Wang X; Chen J; Lv W; Shi B; Wang H; Luo J; Li J Curr Med Res Opin; 2018 May; 34(5):873-880. PubMed ID: 29298525 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]